| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
61,866 |
60,339 |
$10.54M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
22,785 |
21,102 |
$7.96M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,656 |
3,593 |
$557K |
| 71045 |
Radiologic examination, chest; single view |
23,710 |
22,760 |
$410K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,695 |
6,547 |
$274K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,077 |
5,559 |
$253K |
| 87430 |
|
18,755 |
18,430 |
$222K |
| 80053 |
Comprehensive metabolic panel |
13,652 |
12,586 |
$220K |
| 87275 |
|
19,162 |
18,785 |
$206K |
| 87276 |
|
19,161 |
18,783 |
$204K |
| 87070 |
|
13,980 |
13,719 |
$151K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,934 |
2,369 |
$78K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,069 |
939 |
$75K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,173 |
4,606 |
$74K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
428 |
420 |
$70K |
| 85027 |
|
22,374 |
20,047 |
$66K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
849 |
784 |
$65K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,620 |
6,462 |
$55K |
| 81025 |
|
9,828 |
9,227 |
$52K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,404 |
1,263 |
$50K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,573 |
1,532 |
$35K |
| 81001 |
|
9,225 |
8,701 |
$24K |
| 84484 |
|
4,285 |
3,290 |
$22K |
| 87280 |
|
1,693 |
1,665 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
2,575 |
1,931 |
$15K |
| 84702 |
|
1,135 |
955 |
$14K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,664 |
2,311 |
$14K |
| 83690 |
|
4,584 |
4,280 |
$12K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,998 |
1,628 |
$12K |
| 76830 |
Ultrasound, transvaginal |
117 |
107 |
$11K |
| 81003 |
|
1,068 |
986 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
900 |
840 |
$10K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
85 |
81 |
$8K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,600 |
1,317 |
$6K |
| 76801 |
|
44 |
42 |
$5K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
259 |
227 |
$4K |
| 83880 |
|
1,252 |
1,106 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,090 |
872 |
$4K |
| 81000 |
|
595 |
555 |
$4K |
| 80047 |
|
57 |
48 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
691 |
594 |
$2K |
| 86901 |
|
899 |
842 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
14 |
14 |
$982.32 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
12 |
$962.80 |
| 71046 |
Radiologic examination, chest; 2 views |
135 |
129 |
$958.50 |
| 85730 |
|
1,078 |
953 |
$929.27 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
26 |
24 |
$901.79 |
| 85610 |
|
1,365 |
1,195 |
$854.12 |
| A9270 |
Non-covered item or service |
1,961 |
1,000 |
$847.39 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
69 |
63 |
$730.80 |
| 82016 |
|
87 |
81 |
$574.56 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
968 |
707 |
$543.77 |
| 82128 |
|
87 |
81 |
$519.85 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
48 |
48 |
$508.19 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
975 |
796 |
$469.86 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
48 |
48 |
$457.44 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
381 |
368 |
$422.46 |
| 86850 |
|
40 |
36 |
$383.54 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
410 |
326 |
$317.13 |
| 74018 |
|
14 |
13 |
$283.14 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
12 |
$256.71 |
| 86900 |
|
152 |
140 |
$208.90 |
| 81002 |
|
65 |
64 |
$160.27 |
| 87081 |
|
56 |
53 |
$136.60 |
| 83735 |
|
214 |
176 |
$118.85 |
| 36416 |
|
872 |
712 |
$111.88 |
| 87077 |
|
37 |
28 |
$74.69 |
| 87186 |
|
30 |
28 |
$65.43 |
| 87040 |
|
19 |
12 |
$43.35 |
| 83605 |
|
49 |
40 |
$38.88 |
| 84703 |
|
12 |
12 |
$37.92 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
37 |
36 |
$19.17 |
| 82248 |
|
75 |
64 |
$14.75 |
| J3490 |
Unclassified drugs |
14 |
12 |
$13.28 |
| 80076 |
|
64 |
57 |
$12.92 |
| 84100 |
|
32 |
25 |
$4.36 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
202 |
187 |
$0.00 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
87 |
81 |
$0.00 |